FDA backs Pfizer COVID-19 boosters for seniors, high-risk

The uncertainties were yet another reminder that the science surrounding boosters is more complicated than the Biden administration suggested when the president and his top aides rolled out their plan at the White House last month.


You may also like

Brent crude oil

Brent crude oil

Crude oil

Crude oil